Who Supplies Ranitidine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Ranitidine exports, with 248+ registered manufacturers shipping to buyers across 104+ countries — yet a handful of companies dominate the shipments. COMBITIC GLOBAL CAPLET PRIVATE LIMITED holds the largest share at 18.7% (export value: $2.3M). Close behind, EMCURE PHARMACEUTICALS LIMITED (15.9%, $2.0M). LINCOLN PHARMACEUTICALS LTD (7.2%, $905.1K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Ranitidine? Top Manufacturers & Their Buyers
Flow of Ranitidine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Ranitidine Supplier Network — Key Market Intelligence
The Ranitidine export market from India is led by COMBITIC GLOBAL CAPLET PRIVATE LIMITED, which alone commands a 18.7% share, shipping $2.3M worth of product across 68 shipments. The second-largest exporter, EMCURE PHARMACEUTICALS LIMITED, contributes $2.0M (15.9%) to the overall market. Combined, the top two suppliers alone account for 34.6% of all Ranitidine exports, indicating a relatively concentrated supply base.
Across all 248 tracked manufacturers, the total Ranitidine export value stands at $12.6M from 2.0K shipments. The market average shipment value is $6.3K. The single largest buyer relationship in terms of trade value is OOO SMARTPHARMO, receiving $1.8M worth of product.
The combined buyer network spans 12 named purchasing companies, including OOO SMARTPHARMO, BIOMEDIKAL LLC, SHAMS NOORI PHARMA T, MUHABAT LTD., MARCAN PHARMACEUTICALS INC., and 7 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1COMBITIC GLOBAL CAPLET PRIVATE LIMITED
COMBITIC GLOBAL CAPLET PRIVATE LIMITED is the first-largest Ranitidine exporter from India, with a market share of 18.7% and a total export value of $2.3M across 68 shipments. Their average shipment value of $34.6K is above the market average of $6.3K, suggesting premium or bulk contract pricing.
COMBITIC GLOBAL CAPLET PRIVATE LIMITED serves 5 named buyers in our database. OOO SMARTPHARMO is the dominant customer, accounting for 76.3% of this supplier's tracked business. Top customers include:
• OOO SMARTPHARMO — $1.8M across 52 shipments (76.3% of this supplier's total exports)
• BIOMEDIKAL LLC — $449.9K across 13 shipments (19.1% of this supplier's total exports)
• SHAMS NOORI PHARMA T — $61.6K across 2 shipments (2.6% of this supplier's total exports)
• SHAMS NOORI PHARMA T — $24.2K across 1 shipments (1.0% of this supplier's total exports)
• MUHABAT LTD. — $21.7K across 1 shipments (0.9% of this supplier's total exports)
Key Insight: COMBITIC GLOBAL CAPLET PRIVATE LIMITED's per-shipment value of $34.6K is 448% above the market average of $6.3K, consistent with large-order contracts or value-added formulations.
2EMCURE PHARMACEUTICALS LIMITED
EMCURE PHARMACEUTICALS LIMITED is the second-largest Ranitidine exporter from India, with a market share of 15.9% and a total export value of $2.0M across 71 shipments. Their average shipment value of $28.2K is above the market average of $6.3K, suggesting premium or bulk contract pricing.
EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. MARCAN PHARMACEUTICALS INC., is the dominant customer, accounting for 50.6% of this supplier's tracked business. Top customers include:
• MARCAN PHARMACEUTICALS INC., — $1.0M across 36 shipments (50.6% of this supplier's total exports)
• MARCAN PHARMACEUTICALS INC., — $700.9K across 25 shipments (35.0% of this supplier's total exports)
• MARCAN PHARMACEUTICALS INC., — $162.1K across 6 shipments (8.1% of this supplier's total exports)
• MARCAN PHARMACEUTICALS INC., — $126.8K across 4 shipments (6.3% of this supplier's total exports)
• MARCAN PHARMA — $61 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LIMITED's per-shipment value of $28.2K is 348% above the market average of $6.3K, consistent with large-order contracts or value-added formulations.
3LINCOLN PHARMACEUTICALS LTD
LINCOLN PHARMACEUTICALS LTD is the third-largest Ranitidine exporter from India, with a market share of 7.2% and a total export value of $905.1K across 3 shipments. Their average shipment value of $301.7K is above the market average of $6.3K, suggesting premium or bulk contract pricing.
LINCOLN PHARMACEUTICALS LTD serves 1 named buyer in our database. UNIVERSAL CO. LTD. is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• UNIVERSAL CO. LTD. — $905.1K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: LINCOLN PHARMACEUTICALS LTD's per-shipment value of $301.7K is 4687% above the market average of $6.3K, consistent with large-order contracts or value-added formulations.
4CADILA PHARMACEUTICALS LIMITED
CADILA PHARMACEUTICALS LIMITED is the fourth-largest Ranitidine exporter from India, with a market share of 3.2% and a total export value of $408.4K across 58 shipments. Their average shipment value of $7.0K is above the market average of $6.3K, suggesting premium or bulk contract pricing.
CADILA PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• SUNSHINE HEALTHCARE LANKA LIMITED — $105.6K across 15 shipments (25.9% of this supplier's total exports)
• SUNSHINE HEALTHCARE LANKA LIMITED — $93.9K across 13 shipments (23.0% of this supplier's total exports)
• EURIMEX PHARMA — $86.4K across 12 shipments (21.1% of this supplier's total exports)
• MODEX CONGO SPRL — $65.7K across 9 shipments (16.1% of this supplier's total exports)
• SUNSHINE HEALTHCARE LANKA LIMITED — $56.9K across 8 shipments (13.9% of this supplier's total exports)
Key Insight: CADILA PHARMACEUTICALS LIMITED's per-shipment value of $7.0K is 12% above the market average of $6.3K, consistent with large-order contracts or value-added formulations.
5AGILE MEDLINK
AGILE MEDLINK is the fifth-largest Ranitidine exporter from India, with a market share of 3.2% and a total export value of $404.0K across 11 shipments. Their average shipment value of $36.7K is above the market average of $6.3K, suggesting premium or bulk contract pricing.
AGILE MEDLINK serves 3 named buyers in our database. TO THE ORDER is the dominant customer, accounting for 59.1% of this supplier's tracked business. Top customers include:
• TO THE ORDER — $238.8K across 7 shipments (59.1% of this supplier's total exports)
• TO THE — $91.4K across 2 shipments (22.6% of this supplier's total exports)
• TO — $73.9K across 2 shipments (18.3% of this supplier's total exports)
Key Insight: AGILE MEDLINK's per-shipment value of $36.7K is 483% above the market average of $6.3K, consistent with large-order contracts or value-added formulations.
6CAPLIN POINT LABORATORIES LIMITED
CAPLIN POINT LABORATORIES LIMITED is the fifth-largest Ranitidine exporter from India, with a market share of 0.9% and a total export value of $119.4K across 14 shipments. Their average shipment value of $8.5K is above the market average of $6.3K, suggesting premium or bulk contract pricing.
CAPLIN POINT LABORATORIES LIMITED serves 2 named buyers in our database. NEOETHICALS, S.A is the dominant customer, accounting for 72.3% of this supplier's tracked business. Top customers include:
• NEOETHICALS, S.A — $86.2K across 10 shipments (72.3% of this supplier's total exports)
• NEOETHICALS, S.A — $33.1K across 4 shipments (27.7% of this supplier's total exports)
Key Insight: CAPLIN POINT LABORATORIES LIMITED's per-shipment value of $8.5K is 35% above the market average of $6.3K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Ranitidine Flows
Once Ranitidine leaves the manufacturing plants of companies like COMBITIC GLOBAL CAPLET PRIVATE LIMITED and EMCURE PHARMACEUTICALS LIMITED, it travels to 5 destination markets with a combined import value of $12.6M. Uzbekistan absorbs the largest share at 20.7% ($2.6M), followed by Canada (19.3%) and Myanmar (17.1%).
In Uzbekistan — the top destination — named importers include OOO SMARTPHARMO, BIOMEDIKAL LLC. In Canada, key buyers are MARCAN PHARMACEUTICALS INC., MARCAN PHARMACEUTICALS INC, MARCAN PHARMACEUTICALS INC.,.
This geographic spread reflects Ranitidine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Ranitidine Go? Top Importing Countries & Their Buyers
Trade flow of Ranitidine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Uzbekistan
Uzbekistan ranks as the first-largest destination for Ranitidine imports from India, with a total trade value of $2.6M across 25 shipments — representing a 20.7% share of all Ranitidine exports. The average shipment value of $104.2K is above the global average of $6.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Ranitidine importers in Uzbekistan: OOO SMARTPHARMO is the largest buyer, accounting for 71.0% ($1.8M) of this market's total imports.
• OOO SMARTPHARMO — $1.8M (71.0% of Uzbekistan's total)
• BIOMEDIKAL LLC — $501.7K (19.3% of Uzbekistan's total)
Key Insight: Uzbekistan's per-shipment average of $104.2K (1553% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Uzbekistan is a key market for Ranitidine imports from India.
2Canada
Canada ranks as the second-largest destination for Ranitidine imports from India, with a total trade value of $2.4M across 62 shipments — representing a 19.3% share of all Ranitidine exports. The average shipment value of $39.2K is above the global average of $6.3K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Ranitidine importers in Canada: MARCAN PHARMACEUTICALS INC. is the largest buyer, accounting for 48.0% ($1.2M) of this market's total imports.
• MARCAN PHARMACEUTICALS INC. — $1.2M (48.0% of Canada's total)
• MARCAN PHARMACEUTICALS INC — $712.7K (29.3% of Canada's total)
• MARCAN PHARMACEUTICALS INC., — $206.5K (8.5% of Canada's total)
Key Insight: Canada's per-shipment average of $39.2K (522% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Ranitidine imports from India.
3Myanmar
Myanmar ranks as the third-largest destination for Ranitidine imports from India, with a total trade value of $2.2M across 56 shipments — representing a 17.1% share of all Ranitidine exports. The average shipment value of $38.5K is above the global average of $6.3K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Ranitidine importers in Myanmar: UNIVERSAL CO. LTD. is the largest buyer, accounting for 42.2% ($910.5K) of this market's total imports.
• UNIVERSAL CO. LTD. — $910.5K (42.2% of Myanmar's total)
• AORTA COMPANY LIMITED — $336.8K (15.6% of Myanmar's total)
• SUCCESS EMPIRE TRANSPORTATION & — $250.7K (11.6% of Myanmar's total)
Key Insight: Myanmar's per-shipment average of $38.5K (511% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Myanmar is a key market for Ranitidine imports from India.
4Peru
Peru ranks as the fourth-largest destination for Ranitidine imports from India, with a total trade value of $592.5K across 0 shipments — representing a 4.7% share of all Ranitidine exports. The average shipment value of $592.5K is above the global average of $6.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Peru's per-shipment average of $592.5K (9300% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Peru is a key market for Ranitidine imports from India.
5Sri Lanka
Sri Lanka ranks as the fifth-largest destination for Ranitidine imports from India, with a total trade value of $444.1K across 24 shipments — representing a 3.5% share of all Ranitidine exports. The average shipment value of $18.5K is above the global average of $6.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ranitidine importers in Sri Lanka: SUNSHINE HEALTHCARE LANKA LIMITED is the largest buyer, accounting for 34.8% ($154.4K) of this market's total imports.
• SUNSHINE HEALTHCARE LANKA LIMITED — $154.4K (34.8% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $18.5K (194% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Ranitidine imports from India.
People Also Ask — Ranitidine Supplier & Trade Network
Who are the top suppliers of Ranitidine from India?+
Which companies buy Ranitidine from Indian manufacturers?+
Where does Ranitidine exported from India go?+
What is the market share of the top Ranitidine supplier from India?+
What is the average shipment value for Ranitidine exports from India?+
Is Ranitidine manufactured in India and exported globally?+
Which country imports the most Ranitidine from India?+
Who are the buyers of Ranitidine in Canada?+
How concentrated is the Ranitidine supplier market in India?+
How do I find verified buyers for Ranitidine in specific countries?+
Ranitidine Trade Network — Key Takeaways
- 1COMBITIC GLOBAL CAPLET PRIVATE LIMITED is India's dominant Ranitidine exporter with a 18.7% market share and $2.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 248 suppliers collectively account for 49.2% of all tracked Ranitidine exports, with a combined trade value of $12.6M.
- 3Uzbekistan is the largest destination market, absorbing 20.7% of India's Ranitidine exports ($2.6M). Canada (19.3%) and Myanmar (17.1%) follow.
- 4With 2.0K total shipments averaging $6.3K each, the Ranitidine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include OOO SMARTPHARMO, BIOMEDIKAL LLC, MARCAN PHARMACEUTICALS INC.,, MARCAN PHARMACEUTICALS INC., — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 104 countries
Network value: $12.6M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ranitidine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ranitidine.
- 2.Flow Mapping: 248 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,996 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 104 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,996 Verified Shipments
248 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists